Ledger.Open graph →
SEC Form D · filed November 17, 2020

ADARx Pharmaceuticals, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Hongbo Lu · San Diego, CADirectorSheila Gujrathi · San Diego, CADirectorErez Chimovits · San Diego, CADirectorCarl Gordon · San Diego, CADirectorRui Zhu · San Diego, CAExecZhen Li · San Diego, CAExec · DirectorCary Marr · GEORGE TOWN GRAND CAYMAN, Cayman IslandsDirectorDaryl Brooks · Grandview, TXExec · DirectorCharles Reim · San Francisco, CADirectorKevin E. Marchetti · Novi, MIDirectorRuwack Trust · GREENSBORO, NCExecYonatan Goodman · New York, NYDirectorJames D. Rippeto, Jr · Houston, TXExec · DirectorGurwinder Singh · Jericho, NYExecPaul Song · Los Angeles, CADirectorJeffrey Takimoto · Los Angeles, CADirectorKevin Phillip · Grand Cayman, Cayman IslandsDirectorRoger A. Mills · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗